Tibet Aim Pharm Inc Total Liabilities

Latest as of March 2026: CN¥265.27 Million CNY ≈ $38.82 Million USD

Tibet Aim Pharm Inc total liabilities. Based on the latest financial reports, Tibet Aim Pharm Inc (002826) has total liabilities worth CN¥265.27 Million CNY (≈ $38.82 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 002826 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Tibet Aim Pharm Inc (2013–2025)

Total liabilities of Tibet Aim Pharm Inc from 2013 to 2025. This chart illustrates how Tibet Aim Pharm Inc's total liabilities have evolved over time, based on quarterly financial data. Explore how much of Tibet Aim Pharm Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.

Tibet Aim Pharm Inc Competitors by Total Liabilities

The table below lists competitors of Tibet Aim Pharm Inc ranked by their total liabilities.

Company Country Total Liabilities
DRB - Hicom Bhd
KLSE:1619
Malaysia RM57.43 Billion
Hiper Global Ltd
TA:HIPR
Israel ILA180.92 Million
Nanjing CEC Environmental Protect
SHE:300172
China CN¥890.42 Million
Abm Investama Tbk
JK:ABMM
Indonesia Rp1.22 Billion
Bank Artos Indonesia Tbk PT
JK:ARTO
Indonesia Rp30.62 Trillion
DIAMOND BIOFUND INC
TW:6901
Taiwan NT$137.79 Million
YTL Hospitality REIT
KLSE:5109
Malaysia RM2.51 Billion
Verra Mobility Corp
NASDAQ:VRRM
USA $1.39 Billion

Liability Composition Analysis (2013–2025)

This chart breaks down Tibet Aim Pharm Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Tibet Aim Pharm Inc.

Liquidity & Leverage Metrics

Tibet Aim Pharm Inc Total Liabilities Ratios Explained

Tibet Aim Pharm Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 2.78 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.32 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.24 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Tibet Aim Pharm Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Tibet Aim Pharm Inc (2013–2025)

The table below shows the annual total liabilities of Tibet Aim Pharm Inc from 2013 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥201.65 Million
≈ $29.51 Million
+11.48%
2024-12-31 CN¥180.89 Million
≈ $26.47 Million
+1.81%
2023-12-31 CN¥177.68 Million
≈ $26.00 Million
-33.75%
2022-12-31 CN¥268.21 Million
≈ $39.25 Million
+157.00%
2021-12-31 CN¥104.36 Million
≈ $15.27 Million
-52.76%
2020-12-31 CN¥220.94 Million
≈ $32.33 Million
+20.58%
2019-12-31 CN¥183.24 Million
≈ $26.81 Million
+31.32%
2018-12-31 CN¥139.53 Million
≈ $20.42 Million
+8.36%
2017-12-31 CN¥128.76 Million
≈ $18.84 Million
+41.61%
2016-12-31 CN¥90.93 Million
≈ $13.31 Million
-39.16%
2015-12-31 CN¥149.44 Million
≈ $21.87 Million
+67.36%
2014-12-31 CN¥89.30 Million
≈ $13.07 Million
+9.66%
2013-12-31 CN¥81.43 Million
≈ $11.92 Million
--

About Tibet Aim Pharm Inc

SHE:002826 China Drug Manufacturers - Specialty & Generic
Market Cap
$404.86 Million
CN¥2.77 Billion CNY
Market Cap Rank
#12979 Global
#3789 in China
Share Price
CN¥14.51
Change (1 day)
-1.36%
52-Week Range
CN¥14.51 - CN¥22.24
All Time High
CN¥32.76
About

Tibet AIM Pharm. Inc. engages in the research and development, manufacturing, and sale of medical products in China. The company's products include Miglitol tablets for diabetes; ethnic medicine products, suitable for treating breast lobular hyperplasia, uterine fibroids, and ovarian cysts; gynecology and obstetrics; and NalMefene hydrochloride injection for various acute poisoning, such as alcoh… Read more